TrialJAMA cardiology2017

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.

Robert P Giugliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.